• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2021 年 5 月,芬兰一家二级保健医院发生的由 SARS-CoV-2 德尔塔变异株(B.1.617.2)引起的暴发。

An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a secondary care hospital in Finland, May 2021.

机构信息

Infectious Diseases Unit, Kanta-Häme Central Hospital, Hämeenlinna, Finland.

Translational Immunology Program, Helsinki University and Helsinki University Central Hospital, Helsinki, Finland.

出版信息

Euro Surveill. 2021 Jul;26(30). doi: 10.2807/1560-7917.ES.2021.26.30.2100636.

DOI:10.2807/1560-7917.ES.2021.26.30.2100636
PMID:34328076
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8323455/
Abstract

An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) spread from one inpatient in a secondary care hospital to three primary care facilities, resulting in 58 infections including 18 deaths in patients and 45 infections in healthcare workers (HCW). Only one of the deceased cases was fully vaccinated. Transmission occurred despite the use of personal protective equipment by the HCW, as advised in national guidelines, and a high two-dose COVID-19 vaccination coverage among permanent staff members in the COVID-19 cohort ward.

摘要

由 SARS-CoV-2 Delta 变异株(B.1.617.2)引起的疫情从一家二级医疗机构的一名住院患者传播到三家基层医疗机构,导致 58 例感染,包括患者 18 例死亡和医护人员(HCW)45 例感染。在去世的病例中,只有一人完全接种了疫苗。尽管 HCW 按照国家指南建议使用了个人防护设备,而且 COVID-19 队列病房的常驻工作人员也进行了高两剂 COVID-19 疫苗接种,但仍发生了传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/117c/8323455/3e5054bcd046/2100636-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/117c/8323455/3e5054bcd046/2100636-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/117c/8323455/3e5054bcd046/2100636-f1.jpg

相似文献

1
An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a secondary care hospital in Finland, May 2021.2021 年 5 月,芬兰一家二级保健医院发生的由 SARS-CoV-2 德尔塔变异株(B.1.617.2)引起的暴发。
Euro Surveill. 2021 Jul;26(30). doi: 10.2807/1560-7917.ES.2021.26.30.2100636.
2
A two-ward acute care hospital outbreak of SARS-CoV-2 delta variant including a point-source outbreak associated with the use of a mobile vital signs cart and sub-optimal doffing of personal protective equipment.一家拥有两个病房的急性护理医院暴发了 SARS-CoV-2 德尔塔变异株疫情,其中包括一起与使用移动生命体征车以及个人防护设备脱卸不当有关的同源性暴发事件。
J Hosp Infect. 2023 Jan;131:1-11. doi: 10.1016/j.jhin.2022.09.019. Epub 2022 Oct 3.
3
Investigation of an outbreak of symptomatic SARS-CoV-2 VOC 202012/01-lineage B.1.1.7 infection in healthcare workers, Italy.意大利医护人员感染有症状的 SARS-CoV-2 VOC 202012/01 谱系 B.1.1.7 的暴发调查。
Clin Microbiol Infect. 2021 Aug;27(8):1174.e1-1174.e4. doi: 10.1016/j.cmi.2021.05.007. Epub 2021 May 10.
4
An Outbreak of Breakthrough Infections by the SARS-CoV-2 Delta Variant in a Psychiatric Closed Ward.一起德尔塔变异株引起的精神科封闭病房突破性感染事件
J Korean Med Sci. 2022 Jan 24;37(4):e28. doi: 10.3346/jkms.2022.37.e28.
5
[Evaluation of Healthcare Professionals in Contact with Patients Diagnosed with COVID-19 Detected Outside of the Pandemic Service in our Hospital].[对我院大流行服务范围之外确诊感染新冠病毒患者的医护人员的评估]
Mikrobiyol Bul. 2021 Apr;55(2):194-206. doi: 10.5578/mb.20219906.
6
Transmission of SARS-CoV-2 variant B.1.1.7 among vaccinated health care workers.接种疫苗的医护人员中 SARS-CoV-2 变异株 B.1.1.7 的传播。
Infect Dis (Lond). 2021 Nov;53(11):876-879. doi: 10.1080/23744235.2021.1945139. Epub 2021 Jun 26.
7
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.辉瑞-生物科技和 Moderna 疫苗在 SARS-CoV-2 B.1.617.2(Delta)变异株广泛传播之前和期间预防养老院居民感染 SARS-CoV-2 的有效性 - 国家医疗保健安全网络,2021 年 3 月 1 日至 8 月 1 日。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1163-1166. doi: 10.15585/mmwr.mm7034e3.
8
A SARS-CoV-2 outbreak associated with vaccine breakthrough in an acute care hospital.一起与疫苗突破相关的 SARS-CoV-2 爆发,发生于一家急症护理医院。
Am J Infect Control. 2022 Sep;50(9):1006-1012. doi: 10.1016/j.ajic.2022.05.010. Epub 2022 May 20.
9
Healthcare Workers' SARS-CoV-2 Infections in Four Hospital Outbreaks during Delta Variant Prevalence in Sydney, Australia.澳大利亚悉尼德尔塔变异株流行期间四家医院暴发疫情中医护人员的新冠病毒感染情况
Nurs Res Pract. 2023 Sep 14;2023:1806909. doi: 10.1155/2023/1806909. eCollection 2023.
10
Staff to staff transmission as a driver of healthcare worker infections with COVID-19.医护人员间传播是导致 COVID-19 医护人员感染的一个因素。
Infect Dis Health. 2021 Nov;26(4):276-283. doi: 10.1016/j.idh.2021.06.003. Epub 2021 Jul 17.

引用本文的文献

1
Mucormycosis in patients infected with the delta strain of COVID-19 virus, effective of some factors in the prevalence and patient prognosis in Shahid Beheshti Hospital, Kashan, central Iran.感染新冠病毒德尔塔毒株患者的毛霉菌病,伊朗中部卡尚市沙希德·贝赫什提医院某些因素对患病率及患者预后的影响
Caspian J Intern Med. 2025 Mar 11;16(2):239-245. doi: 10.22088/cjim.16.2.239. eCollection 2025.
2
A Comprehensive Review of mRNA-based Vaccines for COVID-19, A New Era in Pharmaceuticals: Unspecified and Unknown Aspects, Effects and Challenges.新型冠状病毒肺炎mRNA疫苗综合综述:制药新时代的未明确及未知方面、影响与挑战
Curr Top Med Chem. 2025;25(12):1467-1491. doi: 10.2174/0115680266325847241121034100.
3

本文引用的文献

1
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.Covid-19 疫苗对 B.1.617.2(德尔塔)变异株的有效性。
N Engl J Med. 2021 Aug 12;385(7):585-594. doi: 10.1056/NEJMoa2108891. Epub 2021 Jul 21.
2
Aerosol generating procedures: are they of relevance for transmission of SARS-CoV-2?气溶胶生成程序:它们与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的传播有关吗?
Lancet Respir Med. 2021 Jul;9(7):687-689. doi: 10.1016/S2213-2600(21)00216-2. Epub 2021 May 6.
3
Sources of healthcare workers' COVID‑19 infections and related safety guidelines.
Advancements in Structural Basis of Covalent Inhibitors Targeting SARS-CoV-2 Essential Proteins.
靶向严重急性呼吸综合征冠状病毒2(SARS-CoV-2)关键蛋白的共价抑制剂的结构基础研究进展
Curr Med Chem. 2025;32(19):3790-3824. doi: 10.2174/0109298673323348241208080419.
4
Risk of nosocomial coronavirus disease 2019: comparison between single- and multiple-occupancy rooms.医院获得性 2019 冠状病毒病风险:单人间和多人间的比较。
Antimicrob Resist Infect Control. 2024 Aug 30;13(1):95. doi: 10.1186/s13756-024-01454-w.
5
SARS-CoV-2 aerosol transmission and detection.严重急性呼吸综合征冠状病毒2型气溶胶传播与检测
Eco Environ Health. 2022 Apr 15;1(1):3-10. doi: 10.1016/j.eehl.2022.03.001. eCollection 2022 Mar.
6
The burden and dynamics of hospital-acquired SARS-CoV-2 in England.英格兰医院获得性 SARS-CoV-2 的负担和动态。
Nature. 2023 Nov;623(7985):132-138. doi: 10.1038/s41586-023-06634-z. Epub 2023 Oct 18.
7
Transmission and Risk Factors of COVID-19 among Health Care Workers.医务人员中 COVID-19 的传播和危险因素。
Semin Respir Crit Care Med. 2023 Jun;44(3):340-348. doi: 10.1055/s-0043-1766118. Epub 2023 Apr 4.
8
Impact of supplementary air filtration on aerosols and particulate matter in a UK hospital ward: a case study.英国医院病房补充空气过滤对气溶胶和颗粒物的影响:一项案例研究。
J Hosp Infect. 2023 May;135:81-89. doi: 10.1016/j.jhin.2023.02.006. Epub 2023 Feb 24.
9
Epidemiology of healthcare-associated SARS-CoV-2 outbreaks in Germany between March 2020 and May 2022.德国 2020 年 3 月至 2022 年 5 月期间与医疗保健相关的 SARS-CoV-2 疫情爆发的流行病学。
J Hosp Infect. 2023 Apr;134:108-120. doi: 10.1016/j.jhin.2023.01.011. Epub 2023 Feb 3.
10
Environmental Dissemination of SARS-CoV-2 in a University Hospital during the COVID-19 5th Wave Delta Variant Peak in Castile-León, Spain.西班牙卡斯蒂利亚-莱昂地区第五波德尔塔变异株流行期间一家大学医院中 SARS-CoV-2 的环境传播
Int J Environ Res Public Health. 2023 Jan 15;20(2):1574. doi: 10.3390/ijerph20021574.
医护人员感染 COVID-19 的来源及相关安全指南。
Int J Occup Med Environ Health. 2021 May 27;34(2):239-249. doi: 10.13075/ijomeh.1896.01741. Epub 2021 Apr 6.
4
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.在英格兰,估计 SARS-CoV-2 谱系 B.1.1.7 的传染性和影响。
Science. 2021 Apr 9;372(6538). doi: 10.1126/science.abg3055. Epub 2021 Mar 3.
5
Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study.西班牙加泰罗尼亚 282 起聚集性 COVID-19 传播:一项队列研究。
Lancet Infect Dis. 2021 May;21(5):629-636. doi: 10.1016/S1473-3099(20)30985-3. Epub 2021 Feb 2.
6
Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020.2020 年 10 月至 11 月英国 SARS-CoV-2 N501Y 突变株的早期传播能力评估。
Euro Surveill. 2021 Jan;26(1). doi: 10.2807/1560-7917.ES.2020.26.1.2002106.
7
COVID-19-Lessons Learned and Questions Remaining.新冠病毒肺炎吸取的经验教训和遗留问题
Clin Infect Dis. 2021 Jun 15;72(12):2225-2240. doi: 10.1093/cid/ciaa1654.
8
Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong.香港 SARS-CoV-2 感染的聚类和超级传播潜力。
Nat Med. 2020 Nov;26(11):1714-1719. doi: 10.1038/s41591-020-1092-0. Epub 2020 Sep 17.
9
Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors.SARS-CoV-2 的传播:病毒、宿主和环境因素综述。
Ann Intern Med. 2021 Jan;174(1):69-79. doi: 10.7326/M20-5008. Epub 2020 Sep 17.
10
Challenges and Controversies to Testing for COVID-19.新冠病毒检测面临的挑战和争议。
J Clin Microbiol. 2020 Oct 21;58(11). doi: 10.1128/JCM.01695-20.